Dehghan Abbas, Köttgen Anna, Yang Qiong, Hwang Shih-Jen, Kao Wh Linda, Rivadeneira Fernando, Boerwinkle Eric, Levy Daniel, Hofman Albert, Astor Brad C, Benjamin Emelia J, van Duijn Cornelia M, Witteman Jacqueline C, Coresh Josef, Fox Caroline S
Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands.
Lancet. 2008 Dec 6;372(9654):1953-61. doi: 10.1016/S0140-6736(08)61343-4. Epub 2008 Oct 1.
Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout.
Genome-wide association studies were done for serum uric acid in 7699 participants in the Framingham cohort and in 4148 participants in the Rotterdam cohort. Genome-wide significant single nucleotide polymorphisms (SNPs) were replicated in white (n=11 024) and black (n=3843) individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). The SNPs that reached genome-wide significant association with uric acid in either the Framingham cohort (p<5.0 x 10(-8)) or the Rotterdam cohort (p<1.0 x 10(-7)) were evaluated with gout. The results obtained in white participants were combined using meta-analysis.
Three loci in the Framingham cohort and two in the Rotterdam cohort showed genome-wide association with uric acid. Top SNPs in each locus were: missense rs16890979 in SLC2A9 (p=7.0 x 10(-168) and 2.9 x 10(-18) for white and black participants, respectively); missense rs2231142 in ABCG2 (p=2.5 x 10(-60) and 9.8 x 10(-4)), and rs1165205 in SLC17A3 (p=3.3 x 10(-26) and 0.33). All SNPs were direction-consistent with gout in white participants: rs16890979 (OR 0.59 per T allele, 95% CI 0.52-0.68, p=7.0 x 10(-14)), rs2231142 (1.74, 1.51-1.99, p=3.3 x 10(-15)), and rs1165205 (0.85, 0.77-0.94, p=0.002). In black participants of the ARIC study, rs2231142 was direction-consistent with gout (1.71, 1.06-2.77, p=0.028). An additive genetic risk score of high-risk alleles at the three loci showed graded associations with uric acid (272-351 mumol/L in the Framingham cohort, 269-386 mumol/L in the Rotterdam cohort, and 303-426 mumol/L in white participants of the ARIC study) and gout (frequency 2-13% in the Framingham cohort, 2-8% in the Rotterdam cohort, and 1-18% in white participants in the ARIC study).
We identified three genetic loci associated with uric acid concentration and gout. A score based on genes with a putative role in renal urate handling showed a substantial risk for gout.
高尿酸血症是一种遗传性很强的性状,是痛风的关键危险因素。我们旨在识别与血清尿酸浓度和痛风相关的新基因。
对弗雷明汉队列中的7699名参与者和鹿特丹队列中的4148名参与者进行了全基因组关联研究,以研究血清尿酸水平。在参与社区动脉粥样硬化风险研究(ARIC)的白人(n = 11024)和黑人(n = 3843)个体中对全基因组显著的单核苷酸多态性(SNP)进行了重复验证。在弗雷明汉队列(p < 5.0 × 10⁻⁸)或鹿特丹队列(p < 1.0 × 10⁻⁷)中与尿酸达到全基因组显著关联的SNP,对痛风进行了评估。对白人参与者获得的结果进行荟萃分析。
弗雷明汉队列中有三个基因座,鹿特丹队列中有两个基因座与尿酸存在全基因组关联。每个基因座中的顶级SNP分别为:SLC2A9中的错义突变rs16890979(白人参与者中p = 7.0 × 10⁻¹⁶⁸,黑人参与者中p = 2.9 × 10⁻¹⁸);ABCG2中的错义突变rs2231142(p = 2.5 × 10⁻⁶⁰和9.8 × 10⁻⁴),以及SLC17A3中的rs1165205(p = 3.3 × 10⁻²⁶和0.33)。所有SNP在白人参与者中与痛风的关联方向一致:rs16890979(每个T等位基因的OR为0.59,95%CI为0.52 - 0.68,p = 7.0 × 10⁻¹⁴),rs2231142(1.74,1.51 - 1.99,p = 3.3 × 10⁻¹⁵),以及rs1165205(0.85,0.77 - 0.94,p = 0.002)。在ARIC研究的黑人参与者中,rs2231142与痛风的关联方向一致(1.71,1.06 - 2.77,p = 0.028)。三个基因座处高危等位基因的加性遗传风险评分与尿酸呈分级关联(弗雷明汉队列中为272 - 351 μmol/L,鹿特丹队列中为269 - 386 μmol/L,ARIC研究的白人参与者中为303 - 426 μmol/L)以及痛风(弗雷明汉队列中的频率为2 - 13%,鹿特丹队列中为2 - 8%,ARIC研究的白人参与者中为1 - 18%)。
我们识别出了三个与尿酸浓度和痛风相关的基因座。基于在肾脏尿酸处理中具有假定作用的基因的评分显示痛风风险很高。